Jennison Associates
CDLX icon

Jennison Associates’s Cardlytics CDLX Stock Holding History

Jennison Associates’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-5,047
Closed -$474K – 582
2022
Q3 		$474K Sell
5,047
-68,683
-93% -$9.78M ﹤0.01% 586
2022
Q2 		$16.4M Buy
73,730
+14,554
+25% +$4.87M 0.02% 331
2022
Q1 		$32.5M Buy
59,176
+2,184
+4% +$1.32M 0.02% 285
2021
Q4 		$37.7M Buy
56,992
+37,653
+195% +$28.8M 0.02% 271
2021
Q3 		$16.2M Sell
19,339
-11,896
-38% -$12.1M 0.01% 395
2021
Q2 		$39.6M Sell
31,235
-132
-0.4% -$149K 0.03% 261
2021
Q1 		$34.4M Sell
31,367
-365
-1% -$482K 0.03% 274
2020
Q4 		$45.3M Sell
31,732
-28,109
-47% -$30M 0.03% 221
2020
Q3 		$42.2M Buy
59,841
+15,959
+36% +$11.6M 0.03% 213
2020
Q2 		$30.7M Sell
43,882
-497
-1% -$287K 0.03% 235
2020
Q1 		$15.5M Sell
44,379
-3,850
-8% -$2.73M 0.02% 286
2019
Q4 		$30.3M Sell
48,229
-22,043
-31% -$10.8M 0.03% 254
2019
Q3 		$23.6M Sell
70,272
-47,895
-41% -$15.4M 0.02% 294
2019
Q2 		$30.7M Sell
118,167
-6,823
-5% -$1.37M 0.03% 283
2019
Q1 		$20.7M Sell
124,990
-1,445
-1% -$235K 0.02% 351
2018
Q4 		$13.7M Buy
126,435
+46,585
+58% +$7.85M 0.02% 402
2018
Q3 		$20M Sell
79,850
-778
-1% -$167K 0.02% 401
2018
Q2 		$17.5M Sell
80,628
-501
-0.6% -$92.7K 0.02% 416
2018
Q1 		$11.9M Buy
+81,129
New +$13.7M 0.01% 445

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return
WPM
Worldly Partners Management Needham, Massachusetts $118M AUM 19.19% 1-Year Est. Return
GEH
General Equity Holdings Brooklyn, New York $135M AUM 32.96% 1-Year Est. Return
ACM
Alua Capital Management New York $1.13B AUM 8.41% 1-Year Est. Return

Jennison Associates's CDLX Position: Q4 2022 in Review

Jennison Associates sold out of Cardlytics (CDLX) in Q4 2022, closing a stake of 5,047 shares — an estimated $474K sold.

Jennison Associates first reported a position in CDLX in Q1 2018 and held it in 19 quarters. The position peaked at $45.3M in Q4 2020. 121 funds tracked by Wall St. Rank hold CDLX as of Q4 2022.

  • Jennison Associates reported no remaining Cardlytics position as of Q4 2022 after selling out during the quarter.
  • Jennison Associates sold 5,047 Cardlytics shares in Q4 2022, an estimated $474K.
  • Jennison Associates first reported a position in Cardlytics in Q1 2018 and held it in 19 quarters.
  • Jennison Associates's Cardlytics position peaked at $45.3M in Q4 2020.
  • 121 funds tracked by Wall St. Rank held Cardlytics as of Q4 2022.

Based on Jennison Associates's 13F filing for Q4 2022, filed 9 Feb 2023.